This creates opportunity, but it also creates risk. When a product is used in a clinical setting, even a small issue can have ...

"Being able to induce a broad range of specific cardiac disease such as HFpEF, which remains one of the least well understood and hardest heart failure conditions to treat, we hope to aid in the ...

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

From your perspective, how is the market evolving today, and which elements of Korean technology and treatment philosophy are ...

The inventor, Ubokobong Amanam, announced the official launch and commercial distribution of the device in a Facebook post on ...

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic ...

Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

China has approved the world's first commercially cleared invasive brain-computer interface, giving it an early lead in the brain-chip sector. Developed by Neuracle Technology and Tsinghua University, ...

Mass consolidation is sweeping up small medtech organizations. Med device startups and early-stage companies that want to be ...

This week marks the final chapter in our three-month series of exploring America at 250 years old through the lens of some of ...

Investors are directing unprecedented levels of capital toward AI related ventures. Universities are revising academic ...